Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	group II metabotropic glutamate receptor activity	GRM2 GRM3	3.16e-06	2	36	2	GO:0001641
GeneOntologyMolecularFunction	extracellular matrix structural constituent	FBN1 FBN2 VWF MUC17 MUC5AC	2.09e-05	188	36	5	GO:0005201
GeneOntologyMolecularFunction	G protein-coupled glutamate receptor activity	GRM2 GRM3	1.13e-04	9	36	2	GO:0098988
GeneOntologyMolecularFunction	adenylate cyclase inhibiting G protein-coupled glutamate receptor activity	GRM2 GRM3	1.13e-04	9	36	2	GO:0001640
GeneOntologyMolecularFunction	protein domain specific binding	SCNN1A DOCK3 LRP2 SHC4 CRIM1 MUC17 AR UNC13A	1.33e-04	875	36	8	GO:0019904
GeneOntologyMolecularFunction	extracellular matrix constituent conferring elasticity	FBN1 FBN2	2.06e-04	12	36	2	GO:0030023
GeneOntologyMolecularFunction	structural molecule activity conferring elasticity	FBN1 FBN2	2.84e-04	14	36	2	GO:0097493
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	LRP2 STAB2	3.73e-04	16	36	2	GO:0005041
GeneOntologyMolecularFunction	ligand-gated sodium channel activity	SCNN1A ASIC1	4.75e-04	18	36	2	GO:0015280
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	LRP2 STAB2	6.49e-04	21	36	2	GO:0030228
GeneOntologyMolecularFunction	glutamate receptor activity	GRM2 GRM3	1.08e-03	27	36	2	GO:0008066
GeneOntologyMolecularFunction	RNA polymerase II general transcription initiation factor binding	TAF1 AR	1.08e-03	27	36	2	GO:0001091
GeneOntologyMolecularFunction	PDZ domain binding	LRP2 CRIM1 MUC17	1.40e-03	123	36	3	GO:0030165
GeneOntologyMolecularFunction	calcium ion binding	LRP2 FBN1 STAB2 FBN2 UNC13A SLIT3	2.03e-03	749	36	6	GO:0005509
GeneOntologyMolecularFunction	sodium channel activity	SCNN1A ASIC1	3.96e-03	52	36	2	GO:0005272
GeneOntologyMolecularFunction	calcium channel regulator activity	GRM2 GRM3	4.26e-03	54	36	2	GO:0005246
GeneOntologyMolecularFunction	nuclear receptor binding	LRP2 TAF1 AR	4.60e-03	187	36	3	GO:0016922
GeneOntologyMolecularFunction	general transcription initiation factor binding	TAF1 AR	5.94e-03	64	36	2	GO:0140296
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	CRIM1 TEK	6.12e-03	65	36	2	GO:0004714
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	TAF1 AR	6.30e-03	66	36	2	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	TAF1 AR	6.30e-03	66	36	2	GO:0001098
GeneOntologyBiologicalProcess	negative regulation of adenylate cyclase activity	CCR2 GRM2 GRM3	3.28e-06	18	34	3	GO:0007194
GeneOntologyBiologicalProcess	negative regulation of cyclase activity	CCR2 GRM2 GRM3	3.89e-06	19	34	3	GO:0031280
GeneOntologyBiologicalProcess	negative regulation of lyase activity	CCR2 GRM2 GRM3	6.17e-06	22	34	3	GO:0051350
GeneOntologyBiologicalProcess	negative regulation of BMP signaling pathway	LRP2 VWC2 FBN1 CRIM1	8.91e-06	80	34	4	GO:0030514
GeneOntologyBiologicalProcess	enzyme-linked receptor protein signaling pathway	DOCK3 LRP2 SHC4 VWC2 FBN1 FBN2 CRIM1 TEK ZYX AR	1.40e-05	1186	34	10	GO:0007167
GeneOntologyBiologicalProcess	regulation of synaptic transmission, glutamatergic	CCR2 GRM2 GRM3 UNC13A	1.55e-05	92	34	4	GO:0051966
GeneOntologyBiologicalProcess	sequestering of TGFbeta in extracellular matrix	FBN1 FBN2	1.58e-05	4	34	2	GO:0035583
GeneOntologyBiologicalProcess	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	LRP2 VWC2 FBN1 FBN2 CRIM1	2.73e-05	218	34	5	GO:0090101
GeneOntologyBiologicalProcess	regulation of cellular response to growth factor stimulus	LRP2 VWC2 FBN1 FBN2 CRIM1 TEK	5.13e-05	412	34	6	GO:0090287
GeneOntologyBiologicalProcess	cellular response to growth factor stimulus	DOCK3 LRP2 VWC2 FBN1 FBN2 CRIM1 TEK ZYX	5.63e-05	850	34	8	GO:0071363
GeneOntologyBiologicalProcess	regulation of BMP signaling pathway	LRP2 VWC2 FBN1 CRIM1	6.22e-05	131	34	4	GO:0030510
GeneOntologyBiologicalProcess	synaptic transmission, glutamatergic	CCR2 GRM2 GRM3 UNC13A	6.40e-05	132	34	4	GO:0035249
GeneOntologyBiologicalProcess	maintenance of protein location in extracellular region	FBN1 FBN2	7.34e-05	8	34	2	GO:0071694
GeneOntologyBiologicalProcess	response to growth factor	DOCK3 LRP2 VWC2 FBN1 FBN2 CRIM1 TEK ZYX	7.36e-05	883	34	8	GO:0070848
GeneOntologyBiologicalProcess	transforming growth factor beta receptor superfamily signaling pathway	LRP2 VWC2 FBN1 FBN2 CRIM1 ZYX	7.85e-05	445	34	6	GO:0141091
GeneOntologyBiologicalProcess	sensory perception of sour taste	SCNN1A ASIC1	9.43e-05	9	34	2	GO:0050915
GeneOntologyBiologicalProcess	adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway	GRM2 GRM3	9.43e-05	9	34	2	GO:0007196
GeneOntologyBiologicalProcess	negative regulation of cellular response to growth factor stimulus	LRP2 VWC2 FBN1 CRIM1	1.05e-04	150	34	4	GO:0090288
GeneOntologyBiologicalProcess	cell surface receptor protein serine/threonine kinase signaling pathway	LRP2 VWC2 FBN1 FBN2 CRIM1 ZYX	1.22e-04	482	34	6	GO:0007178
GeneOntologyBiologicalProcess	regulation of adenylate cyclase activity	CCR2 GRM2 GRM3	1.25e-04	59	34	3	GO:0045761
GeneOntologyBiologicalProcess	glutamate receptor signaling pathway	GRM2 GRM3 UNC13A	1.25e-04	59	34	3	GO:0007215
GeneOntologyBiologicalProcess	sequestering of extracellular ligand from receptor	FBN1 FBN2	1.44e-04	11	34	2	GO:0035581
GeneOntologyBiologicalProcess	regulation of cyclase activity	CCR2 GRM2 GRM3	1.99e-04	69	34	3	GO:0031279
GeneOntologyBiologicalProcess	extracellular regulation of signal transduction	FBN1 FBN2	2.03e-04	13	34	2	GO:1900115
GeneOntologyBiologicalProcess	extracellular negative regulation of signal transduction	FBN1 FBN2	2.03e-04	13	34	2	GO:1900116
GeneOntologyBiologicalProcess	regulation of lyase activity	CCR2 GRM2 GRM3	2.35e-04	73	34	3	GO:0051339
GeneOntologyBiologicalProcess	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	LRP2 VWC2 FBN1 FBN2 CRIM1	2.44e-04	347	34	5	GO:0090092
GeneOntologyBiologicalProcess	BMP signaling pathway	LRP2 VWC2 FBN1 CRIM1	2.99e-04	197	34	4	GO:0030509
GeneOntologyBiologicalProcess	G protein-coupled glutamate receptor signaling pathway	GRM2 GRM3	3.12e-04	16	34	2	GO:0007216
GeneOntologyBiologicalProcess	response to BMP	LRP2 VWC2 FBN1 CRIM1	4.17e-04	215	34	4	GO:0071772
GeneOntologyBiologicalProcess	cellular response to BMP stimulus	LRP2 VWC2 FBN1 CRIM1	4.17e-04	215	34	4	GO:0071773
GeneOntologyBiologicalProcess	cellular response to aldehyde	ADH5 SCNN1A	4.92e-04	20	34	2	GO:0110096
GeneOntologyBiologicalProcess	cellular response to pH	SCNN1A ASIC1	8.36e-04	26	34	2	GO:0071467
GeneOntologyBiologicalProcess	response to acidic pH	SCNN1A ASIC1	9.02e-04	27	34	2	GO:0010447
GeneOntologyCellularComponent	extracellular matrix	VWC2 FBN1 FBN2 FCGBP VWF MUC17 MUC5AC OTOGL	1.25e-05	656	36	8	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	VWC2 FBN1 FBN2 FCGBP VWF MUC17 MUC5AC OTOGL	1.28e-05	658	36	8	GO:0030312
GeneOntologyCellularComponent	microfibril	FBN1 FBN2	2.22e-04	13	36	2	GO:0001527
GeneOntologyCellularComponent	external side of plasma membrane	SCNN1A LRP2 CCR2 STAB2 VWF MUC17	2.35e-04	519	36	6	GO:0009897
GeneOntologyCellularComponent	synaptic membrane	SHC4 VWC2 GRM2 GRM3 ASIC1 UNC13A	4.38e-04	583	36	6	GO:0097060
GeneOntologyCellularComponent	cell surface	SCNN1A LRP2 CCR2 STAB2 VWF TEK MUC17 ASIC1	4.95e-04	1111	36	8	GO:0009986
GeneOntologyCellularComponent	postsynaptic membrane	SHC4 VWC2 GRM2 GRM3 ASIC1	6.12e-04	405	36	5	GO:0045211
GeneOntologyCellularComponent	astrocyte projection	GRM2 GRM3	8.44e-04	25	36	2	GO:0097449
GeneOntologyCellularComponent	collagen-containing extracellular matrix	VWC2 FBN1 FBN2 VWF MUC17	2.02e-03	530	36	5	GO:0062023
GeneOntologyCellularComponent	glial cell projection	GRM2 GRM3	2.97e-03	47	36	2	GO:0097386
GeneOntologyCellularComponent	dendrite	LRP2 CCR2 GRM2 GRM3 ASIC1 AR	3.19e-03	858	36	6	GO:0030425
GeneOntologyCellularComponent	dendritic tree	LRP2 CCR2 GRM2 GRM3 ASIC1 AR	3.23e-03	860	36	6	GO:0097447
GeneOntologyCellularComponent	side of membrane	SCNN1A LRP2 CCR2 STAB2 VWF MUC17	3.51e-03	875	36	6	GO:0098552
HumanPheno	Abnormal upper to lower segment ratio	FBN1 FBN2	3.14e-05	3	17	2	HP:0012772
Domain	VWC	VWC2 FCGBP VWF CRIM1 MUC5AC	8.24e-09	38	35	5	SM00214
Domain	EGF	LRP2 FBN1 STAB2 FBN2 FCGBP TEK MUC17 SLIT3	9.79e-09	235	35	8	SM00181
Domain	TIL_dom	LRP2 FCGBP VWF MUC5AC	1.02e-08	14	35	4	IPR002919
Domain	Growth_fac_rcpt_	LRP2 FBN1 STAB2 FBN2 CRIM1 TEK SLIT3	1.37e-08	156	35	7	IPR009030
Domain	VWF_dom	VWC2 FCGBP VWF CRIM1 MUC5AC	1.39e-08	42	35	5	IPR001007
Domain	EGF-like_dom	LRP2 FBN1 STAB2 FBN2 FCGBP TEK MUC17 SLIT3	1.54e-08	249	35	8	IPR000742
Domain	VWC_out	FCGBP VWF CRIM1 MUC5AC	3.93e-08	19	35	4	SM00215
Domain	VWC	VWC2 VWF CRIM1 MUC5AC	2.05e-07	28	35	4	PF00093
Domain	EGF_3	LRP2 FBN1 STAB2 FBN2 TEK MUC17 SLIT3	2.27e-07	235	35	7	PS50026
Domain	EGF_1	LRP2 FBN1 STAB2 FBN2 TEK MUC17 SLIT3	3.95e-07	255	35	7	PS00022
Domain	EGF-like_CS	LRP2 FBN1 STAB2 FBN2 TEK MUC17 SLIT3	4.62e-07	261	35	7	IPR013032
Domain	EGF_2	LRP2 FBN1 STAB2 FBN2 TEK MUC17 SLIT3	5.12e-07	265	35	7	PS01186
Domain	VWFC_1	VWC2 VWF CRIM1 MUC5AC	5.83e-07	36	35	4	PS01208
Domain	VWFC_2	VWC2 VWF CRIM1 MUC5AC	7.29e-07	38	35	4	PS50184
Domain	TIL	FCGBP VWF MUC5AC	1.31e-06	12	35	3	PF01826
Domain	C8	FCGBP VWF MUC5AC	1.31e-06	12	35	3	PF08742
Domain	Unchr_dom_Cys-rich	FCGBP VWF MUC5AC	1.70e-06	13	35	3	IPR014853
Domain	C8	FCGBP VWF MUC5AC	1.70e-06	13	35	3	SM00832
Domain	EGF_CA	LRP2 FBN1 STAB2 FBN2 SLIT3	3.04e-06	122	35	5	SM00179
Domain	EGF-like_Ca-bd_dom	LRP2 FBN1 STAB2 FBN2 SLIT3	3.29e-06	124	35	5	IPR001881
Domain	VWFD	FCGBP VWF MUC5AC	3.32e-06	16	35	3	PS51233
Domain	VWD	FCGBP VWF MUC5AC	3.32e-06	16	35	3	SM00216
Domain	VWF_type-D	FCGBP VWF MUC5AC	3.32e-06	16	35	3	IPR001846
Domain	VWD	FCGBP VWF MUC5AC	3.32e-06	16	35	3	PF00094
Domain	CTCK_1	VWF MUC5AC SLIT3	4.83e-06	18	35	3	PS01185
Domain	CT	VWF MUC5AC SLIT3	9.06e-06	22	35	3	SM00041
Domain	FBN	FBN1 FBN2	1.02e-05	3	35	2	IPR011398
Domain	Cys_knot_C	VWF MUC5AC SLIT3	1.35e-05	25	35	3	IPR006207
Domain	CTCK_2	VWF MUC5AC SLIT3	1.35e-05	25	35	3	PS01225
Domain	cEGF	LRP2 FBN1 FBN2	1.52e-05	26	35	3	IPR026823
Domain	cEGF	LRP2 FBN1 FBN2	1.52e-05	26	35	3	PF12662
Domain	EGF_Ca-bd_CS	LRP2 FBN1 FBN2 SLIT3	3.16e-05	97	35	4	IPR018097
Domain	EGF_CA	LRP2 FBN1 FBN2 SLIT3	3.43e-05	99	35	4	PS01187
Domain	EGF-type_Asp/Asn_hydroxyl_site	LRP2 FBN1 FBN2 SLIT3	4.48e-05	106	35	4	IPR000152
Domain	ENaC	SCNN1A ASIC1	7.12e-05	7	35	2	IPR004724
Domain	TB	FBN1 FBN2	7.12e-05	7	35	2	PF00683
Domain	Hirudin/antistatin	CRIM1 MUC5AC	7.12e-05	7	35	2	IPR011061
Domain	-	FBN1 FBN2	9.49e-05	8	35	2	3.90.290.10
Domain	Na+channel_ASC_CS	SCNN1A ASIC1	9.49e-05	8	35	2	IPR020903
Domain	GPCR_3_mtglu_rcpt	GRM2 GRM3	9.49e-05	8	35	2	IPR000162
Domain	ASC	SCNN1A ASIC1	1.22e-04	9	35	2	PF00858
Domain	TB	FBN1 FBN2	1.22e-04	9	35	2	PS51364
Domain	ASC	SCNN1A ASIC1	1.22e-04	9	35	2	PS01206
Domain	Na+channel_ASC	SCNN1A ASIC1	1.22e-04	9	35	2	IPR001873
Domain	TB_dom	FBN1 FBN2	1.22e-04	9	35	2	IPR017878
Domain	EGF_extracell	LRP2 STAB2 TEK	1.92e-04	60	35	3	IPR013111
Domain	EGF_2	LRP2 STAB2 TEK	1.92e-04	60	35	3	PF07974
Domain	NCD3G	GRM2 GRM3	2.63e-04	13	35	2	PF07562
Domain	GPCR_3_9-Cys_dom	GRM2 GRM3	2.63e-04	13	35	2	IPR011500
Domain	GPCR_3_CS	GRM2 GRM3	3.06e-04	14	35	2	IPR017979
Domain	EGF_CA	LRP2 FBN1 FBN2	5.55e-04	86	35	3	PF07645
Domain	GPCR_3	GRM2 GRM3	7.01e-04	21	35	2	IPR000337
Domain	G_PROTEIN_RECEP_F3_4	GRM2 GRM3	7.70e-04	22	35	2	PS50259
Domain	7tm_3	GRM2 GRM3	7.70e-04	22	35	2	PF00003
Domain	GPCR_3_C	GRM2 GRM3	7.70e-04	22	35	2	IPR017978
Domain	G_PROTEIN_RECEP_F3_2	GRM2 GRM3	7.70e-04	22	35	2	PS00980
Domain	G_PROTEIN_RECEP_F3_3	GRM2 GRM3	7.70e-04	22	35	2	PS00981
Domain	G_PROTEIN_RECEP_F3_1	GRM2 GRM3	7.70e-04	22	35	2	PS00979
Domain	ASX_HYDROXYL	LRP2 FBN1 FBN2	8.61e-04	100	35	3	PS00010
Domain	EGF	LRP2 STAB2 SLIT3	1.68e-03	126	35	3	PF00008
Domain	ANF_receptor	GRM2 GRM3	2.18e-03	37	35	2	PF01094
Domain	ANF_lig-bd_rcpt	GRM2 GRM3	2.18e-03	37	35	2	IPR001828
Domain	Peripla_BP_I	GRM2 GRM3	2.42e-03	39	35	2	IPR028082
Pathway	WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE	GRM2 GRM3	3.13e-04	15	25	2	M39442
Pathway	WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE	GRM2 GRM3	3.13e-04	15	25	2	MM15845
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC17 MUC5AC	3.57e-04	16	25	2	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC17 MUC5AC	4.04e-04	17	25	2	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC17 MUC5AC	6.21e-04	21	25	2	MM15706
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC17 MUC5AC	7.47e-04	23	25	2	M556
Pathway	WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE	FBN1 FBN2	8.83e-04	25	25	2	M39713
Pathway	REACTOME_DECTIN_2_FAMILY	MUC17 MUC5AC	9.56e-04	26	25	2	M27483
Pubmed	Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly.	FBN1 FBN2 VWF	8.52e-08	9	36	3	12122015
Pubmed	Characterization of a murine gene expressed from the inactive X chromosome.	GJB1 TAF1 AR	1.67e-07	11	36	3	2034278
Pubmed	The murine interleukin-2 receptor gamma chain gene: organization, chromosomal localization and expression in the adult thymus.	GJB1 TAF1 AR	2.89e-07	13	36	3	7805729
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	LRP2 FBN1 FBN2 MUC5AC	8.94e-07	71	36	4	33541421
Pubmed	Homo- and heterotypic fibrillin-1 and -2 interactions constitute the basis for the assembly of microfibrils.	FBN1 FBN2	1.04e-06	2	36	2	12399449
Pubmed	Selective silencing of individual dendritic branches by an mGlu2-activated potassium conductance in dentate gyrus granule cells.	GRM2 GRM3	1.04e-06	2	36	2	23616537
Pubmed	Fibrillin-1 and fibrillin-2 are essential for formation of thick oxytalan fibers in human nonpigmented ciliary epithelial cells in vitro.	FBN1 FBN2	1.04e-06	2	36	2	21851253
Pubmed	Activation of metabotropic glutamate receptor type 2/3 supports the involvement of the hippocampal mossy fiber pathway on contextual fear memory consolidation.	GRM2 GRM3	1.04e-06	2	36	2	19638469
Pubmed	Enhancement of CA3 hippocampal network activity by activation of group II metabotropic glutamate receptors.	GRM2 GRM3	1.04e-06	2	36	2	21628565
Pubmed	Group II metabotropic glutamate receptor blockade promotes stress resilience in mice.	GRM2 GRM3	1.04e-06	2	36	2	30939596
Pubmed	Fibrillins can co-assemble in fibrils, but fibrillin fibril composition displays cell-specific differences.	FBN1 FBN2	1.04e-06	2	36	2	12429739
Pubmed	New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis.	FBN1 FBN2	1.04e-06	2	36	2	30044367
Pubmed	Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils.	FBN1 FBN2	1.04e-06	2	36	2	21440062
Pubmed	MAGP-2 has multiple binding regions on fibrillins and has covalent periodic association with fibrillin-containing microfibrils.	FBN1 FBN2	1.04e-06	2	36	2	15131124
Pubmed	Decreased striatal dopamine in group II metabotropic glutamate receptor (mGlu2/mGlu3) double knockout mice.	GRM2 GRM3	1.04e-06	2	36	2	24053122
Pubmed	Adaptive Changes in Group 2 Metabotropic Glutamate Receptors Underlie the Deficit in Recognition Memory Induced by Methamphetamine in Mice.	GRM2 GRM3	1.04e-06	2	36	2	38969501
Pubmed	Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction.	GRM2 GRM3	1.04e-06	2	36	2	25583490
Pubmed	Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development.	FBN1 FBN2	1.04e-06	2	36	2	12524050
Pubmed	The mGluR2/3 agonist LY379268 induced anti-reinstatement effects in rats exhibiting addiction-like behavior.	GRM2 GRM3	1.04e-06	2	36	2	23624743
Pubmed	The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection.	GRM2 GRM3	1.04e-06	2	36	2	17670976
Pubmed	Deletion of Metabotropic Glutamate Receptors 2 and 3 (mGlu2 & mGlu3) in Mice Disrupts Sleep and Wheel-Running Activity, and Increases the Sensitivity of the Circadian System to Light.	GRM2 GRM3	1.04e-06	2	36	2	25950516
Pubmed	The effect of mGlu2/3 receptors on synaptic activities to different types of GABAergic interneurons in the anterior cingulate cortex.	GRM2 GRM3	1.04e-06	2	36	2	32525061
Pubmed	Microfibril structure masks fibrillin-2 in postnatal tissues.	FBN1 FBN2	1.04e-06	2	36	2	20404337
Pubmed	Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.	GRM2 GRM3	1.04e-06	2	36	2	19386277
Pubmed	Expression and subcellular distribution of glutamate receptor subunits 2/3 in the developing cerebellar cortex.	GRM2 GRM3	1.04e-06	2	36	2	8838577
Pubmed	The metabotropic glutamate receptor types 2/3 inhibit L-type calcium channels via a pertussis toxin-sensitive G-protein in cultured cerebellar granule cells.	GRM2 GRM3	1.04e-06	2	36	2	7965099
Pubmed	Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice.	GRM2 GRM3	1.04e-06	2	36	2	34330748
Pubmed	Fibrillln mutations in Marfan syndrome and related phenotypes.	FBN1 FBN2	1.04e-06	2	36	2	8791520
Pubmed	Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.	GRM2 GRM3	1.04e-06	2	36	2	25434487
Pubmed	NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.	GRM2 GRM3	1.04e-06	2	36	2	28285415
Pubmed	Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: the metabotropic pathway.	GRM2 GRM3	1.04e-06	2	36	2	24080311
Pubmed	mGlu2/3 receptor in the prelimbic cortex is implicated in stress resilience and vulnerability in mice.	GRM2 GRM3	1.04e-06	2	36	2	34090896
Pubmed	Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices.	FBN1 FBN2	1.04e-06	2	36	2	8120105
Pubmed	The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2.	FBN1 FBN2	1.04e-06	2	36	2	35419902
Pubmed	Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18.	FBN1 FBN2	1.04e-06	2	36	2	8307578
Pubmed	Fibrillin assembly: dimer formation mediated by amino-terminal sequences.	FBN1 FBN2	1.04e-06	2	36	2	10504303
Pubmed	Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils.	FBN1 FBN2	1.04e-06	2	36	2	7744963
Pubmed	Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.	GRM2 GRM3	1.04e-06	2	36	2	22089319
Pubmed	Fibrillin microfibrils in bone physiology.	FBN1 FBN2	1.04e-06	2	36	2	26408953
Pubmed	Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration.	FBN1 FBN2	1.04e-06	2	36	2	18006876
Pubmed	Adaptor Protein ShcD/SHC4 Interacts with Tie2 Receptor to Synergistically Promote Glioma Cell Invasion.	SHC4 TEK	1.04e-06	2	36	2	33495401
Pubmed	Regulation of cocaine-induced reinstatement by group II metabotropic glutamate receptors in the ventral tegmental area.	GRM2 GRM3	1.04e-06	2	36	2	21881873
Pubmed	Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis.	FBN1 FBN2	1.04e-06	2	36	2	24833718
Pubmed	Fractionation of spatial memory in GRM2/3 (mGlu2/mGlu3) double knockout mice reveals a role for group II metabotropic glutamate receptors at the interface between arousal and cognition.	GRM2 GRM3	1.04e-06	2	36	2	21832989
Pubmed	The role of group II metabotropic glutamate receptors in cognition and anxiety: comparative studies in GRM2(-/-), GRM3(-/-) and GRM2/3(-/-) knockout mice.	GRM2 GRM3	1.04e-06	2	36	2	25158312
Pubmed	Nonselective assembly of fibrillin 1 and fibrillin 2 in the rodent ocular zonule and in cultured cells: implications for Marfan syndrome.	FBN1 FBN2	1.04e-06	2	36	2	24265020
Pubmed	In vivo studies of mutant fibrillin-1 microfibrils.	FBN1 FBN2	1.04e-06	2	36	2	20529844
Pubmed	Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development.	FBN1 FBN2	1.04e-06	2	36	2	25524144
Pubmed	Activation of Group II Metabotropic Glutamate Receptors Promotes LTP Induction at Schaffer Collateral-CA1 Pyramidal Cell Synapses by Priming NMDA Receptors.	GRM2 GRM3	1.04e-06	2	36	2	27911756
Pubmed	Fibrillin-1 mutations causing Weill-Marchesani syndrome and acromicric and geleophysic dysplasias disrupt heparan sulfate interactions.	FBN1 FBN2	1.04e-06	2	36	2	23133647
Pubmed	Reduction of group II metabotropic glutamate receptors during development of benzodiazepine dependence.	GRM2 GRM3	1.04e-06	2	36	2	23392308
Pubmed	Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice.	GRM2 GRM3	1.04e-06	2	36	2	20970439
Pubmed	Fibrillins 1 and 2 perform partially overlapping functions during aortic development.	FBN1 FBN2	1.04e-06	2	36	2	16407178
Pubmed	Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice.	GRM2 GRM3	1.04e-06	2	36	2	18720515
Pubmed	Behavioural and biochemical responses to methamphetamine are differentially regulated by mGlu2 and mGlu3 metabotropic glutamate receptors in male mice.	GRM2 GRM3	1.04e-06	2	36	2	34217776
Pubmed	Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.	FBN1 FBN2	1.04e-06	2	36	2	1852206
Pubmed	Metabotropic glutamate receptor 2/3 in the hippocampus of patients with mesial temporal lobe epilepsy, and of rats and mice after pilocarpine-induced status epilepticus.	GRM2 GRM3	1.04e-06	2	36	2	15246118
Pubmed	N-terminal domains of fibrillin 1 and fibrillin 2 direct the formation of homodimers: a possible first step in microfibril assembly.	FBN1 FBN2	1.04e-06	2	36	2	10359653
Pubmed	Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.	GRM2 GRM3	1.04e-06	2	36	2	18853337
Pubmed	Alveolar nonselective channels are ASIC1a/α-ENaC channels and contribute to AFC.	SCNN1A ASIC1	1.04e-06	2	36	2	28283476
Pubmed	Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist.	GRM2 GRM3	1.04e-06	2	36	2	21057775
Pubmed	Hippocampal mossy fiber long-term depression in Grm2/3 double knockout mice.	GRM2 GRM3	1.04e-06	2	36	2	21360593
Pubmed	Atomic force microscopy imaging reveals the formation of ASIC/ENaC cross-clade ion channels.	SCNN1A ASIC1	1.04e-06	2	36	2	26032502
Pubmed	Developmental expression of mGlu2 and mGlu3 in the mouse brain.	GRM2 GRM3	1.04e-06	2	36	2	27818290
Pubmed	Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.	CCR2 FBN1	3.12e-06	3	36	2	31928435
Pubmed	Interaction of tropoelastin with the amino-terminal domains of fibrillin-1 and fibrillin-2 suggests a role for the fibrillins in elastic fiber assembly.	FBN1 FBN2	3.12e-06	3	36	2	10825173
Pubmed	Graded heterogeneity of metabotropic signaling underlies a continuum of cell-intrinsic temporal responses in unipolar brush cells.	GRM2 GRM3	3.12e-06	3	36	2	34620856
Pubmed	Pharmacogenetic analysis of the mGlu2/3 agonist LY2140023 monohydrate in the treatment of schizophrenia.	GRM2 GRM3	3.12e-06	3	36	2	21173788
Pubmed	Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics.	GRM2 GRM3	3.12e-06	3	36	2	24949866
Pubmed	Adamts10 inactivation in mice leads to persistence of ocular microfibrils subsequent to reduced fibrillin-2 cleavage.	FBN1 FBN2	3.12e-06	3	36	2	30201140
Pubmed	The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity.	STAB2 VWF	3.12e-06	3	36	2	30124466
Pubmed	Astrocytic PAR1 and mGluR2/3 control synaptic glutamate time course at hippocampal CA1 synapses.	GRM2 GRM3	3.12e-06	3	36	2	38864289
Pubmed	TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domains.	TAF1 AR	3.12e-06	3	36	2	20181722
Pubmed	Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.	GRM2 GRM3	3.12e-06	3	36	2	25150943
Pubmed	Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation.	FBN1 FBN2	3.12e-06	3	36	2	20855508
Pubmed	mGlu2 and mGlu3 Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects.	GRM2 GRM3	3.12e-06	3	36	2	31735403
Pubmed	Knockdown of ASIC1 and epithelial sodium channel subunits inhibits glioblastoma whole cell current and cell migration.	SCNN1A ASIC1	3.12e-06	3	36	2	19561078
Pubmed	Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein.	FBN1 FBN2	6.24e-06	4	36	2	12429738
Pubmed	Group II metabotropic glutamate receptor interactions with NHERF scaffold proteins: Implications for receptor localization in brain.	GRM2 GRM3	6.24e-06	4	36	2	28392297
Pubmed	Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system.	GRM2 GRM3	6.24e-06	4	36	2	29079293
Pubmed	Inhibition of presynaptic calcium transients in cortical inputs to the dorsolateral striatum by metabotropic GABA(B) and mGlu2/3 receptors.	GRM2 GRM3	6.24e-06	4	36	2	25781000
Pubmed	Human eye development is characterized by coordinated expression of fibrillin isoforms.	FBN1 FBN2	6.24e-06	4	36	2	25406291
Pubmed	Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGF{beta} stimulation of RANKL production.	FBN1 FBN2	6.24e-06	4	36	2	20729550
Pubmed	Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly.	FBN1 FBN2	6.24e-06	4	36	2	25034023
Pubmed	MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium.	CCR2 MUC5AC	6.24e-06	4	36	2	21097527
Pubmed	Comprehensive genetic analysis of relevant four genes in 49 patients with Marfan syndrome or Marfan-related phenotypes.	FBN1 FBN2	6.24e-06	4	36	2	16835936
Pubmed	Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.	GRM2 GRM3	6.24e-06	4	36	2	15619115
Pubmed	tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors.	VWF TEK	6.24e-06	4	36	2	1630810
Pubmed	Wnt Signaling Inhibition Prevents Postnatal Inflammation and Disease Progression in Mouse Congenital Myxomatous Valve Disease.	CCR2 FBN1	6.24e-06	4	36	2	38660802
Pubmed	Effects of mGlu2 or mGlu3 receptor deletions on mGlu2/3 receptor agonist (LY354740)-induced brain c-Fos expression: specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus.	GRM2 GRM3	6.24e-06	4	36	2	16733060
Pubmed	Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2/3 selective antagonist LY341495.	GRM2 GRM3	6.24e-06	4	36	2	19477188
Pubmed	Characterization of Microfibrillar-associated Protein 4 (MFAP4) as a Tropoelastin- and Fibrillin-binding Protein Involved in Elastic Fiber Formation.	FBN1 FBN2	1.04e-05	5	36	2	26601954
Pubmed	SCNN1, an epithelial cell sodium channel gene in the conserved linkage group on mouse chromosome 6 and human chromosome 12.	SCNN1A VWF	1.04e-05	5	36	2	7896277
Pubmed	Targeting the Hprt locus in mice reveals differential regulation of Tie2 gene expression in the endothelium.	VWF TEK	1.04e-05	5	36	2	11015584
Pubmed	Genomic organization and chromosomal localization of mouse Eplg2, a gene encoding a binding protein for the receptor tyrosine kinase elk.	GJB1 AR	1.04e-05	5	36	2	7896266
Pubmed	Role of the Astroglial Glutamate Exchanger xCT in Ventral Hippocampus in Resilience to Stress.	GRM2 GRM3	1.04e-05	5	36	2	29024663
Pubmed	Relaxin regulates fibrillin 2, but not fibrillin 1, mRNA and protein expression by human dermal fibroblasts and murine fetal skin.	FBN1 FBN2	1.04e-05	5	36	2	12590922
Pubmed	Fibrillin-1 interactions with fibulins depend on the first hybrid domain and provide an adaptor function to tropoelastin.	FBN1 FBN2	1.04e-05	5	36	2	17255108
Pubmed	POGLUT2 and POGLUT3 O-glucosylate multiple EGF repeats in fibrillin-1, -2, and LTBP1 and promote secretion of fibrillin-1.	FBN1 FBN2	1.04e-05	5	36	2	34411563
Pubmed	Epithelial cells are the major site of hydroxysteroid (17beta) dehydrogenase 2 and androgen receptor expression in fetal mouse lungs during the period overlapping the surge of surfactant.	VWF AR	1.04e-05	5	36	2	19737616
Interaction	SHC4 interactions	SHC4 TEK AR	7.88e-06	22	36	3	int:SHC4
Interaction	NTN5 interactions	LRP2 FBN1 FBN2	1.03e-05	24	36	3	int:NTN5
Cytoband	3p21.2	DOCK3 GRM2	1.01e-04	19	36	2	3p21.2
Cytoband	Xq13.1	GJB1 TAF1	6.59e-04	48	36	2	Xq13.1
Cytoband	Ensembl 112 genes in cytogenetic band chr3p21	DOCK3 CCR2 GRM2	1.95e-03	316	36	3	chr3p21
GeneFamily	Glutamate metabotropic receptors\|Protein phosphatase 1 regulatory subunits	GRM2 GRM3	5.11e-05	8	25	2	281
GeneFamily	CD molecules\|Mucins	MUC17 MUC5AC	3.79e-04	21	25	2	648
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF142 ZNF883 ZUP1 ZNF513	1.61e-02	718	25	4	28
Coexpression	NABA_ECM_GLYCOPROTEINS	FBN1 FBN2 VWF CRIM1 OTOGL SLIT3	2.25e-07	191	36	6	MM17059
Coexpression	NABA_CORE_MATRISOME	FBN1 FBN2 VWF CRIM1 OTOGL SLIT3	1.70e-06	270	36	6	MM17057
Coexpression	NABA_MATRISOME	VWC2 FBN1 FBN2 VWF CRIM1 MUC17 MUC5AC OTOGL SLIT3	6.55e-06	1008	36	9	MM17056
Coexpression	NABA_ECM_GLYCOPROTEINS	FBN1 FBN2 VWF CRIM1 SLIT3	6.94e-06	196	36	5	M3008
Coexpression	NABA_CORE_MATRISOME	FBN1 FBN2 VWF CRIM1 SLIT3	3.54e-05	275	36	5	M5884
Coexpression	NABA_MATRISOME	VWC2 FBN1 FBN2 VWF CRIM1 MUC17 MUC5AC SLIT3	6.11e-05	1026	36	8	M5889
Coexpression	ROETH_TERT_TARGETS_DN	CCR2 CRIM1	6.56e-05	9	36	2	M2891
Coexpression	GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	SCNN1A LRP2 CRIM1 MUC5AC	1.48e-04	196	36	4	M8683
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SHC4 GJB1 FCGBP MUC5AC MKRN2OS	5.29e-07	198	36	5	5dd2aa7684c36beffa204ca4c04d0501cabac10f
ToppCell	Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Mucous\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SCNN1A GJB1 FCGBP MUC5AC OTOGL	5.43e-07	199	36	5	eb2d1b7e875c5bf833e7a80b43282e12893c34e9
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCR2 NCBP1 STAB2 AR	1.03e-05	169	36	4	20fbf78382fb0ba9a63ab1aa0abc615476994ac5
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SCNN1A GJB1 FCGBP MUC5AC	1.16e-05	174	36	4	e7cca4b6a3935fad61cf2a3d9984ab1ffa1a9447
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SCNN1A GJB1 FCGBP MUC5AC	1.16e-05	174	36	4	ad5b56f0ace6455c033834b931ec870cc0dc9290
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK3 OTOGL UNC13A SLIT3	1.18e-05	175	36	4	316f2ea930437bf1243b1c0f45e6bd864112c6f2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK3 OTOGL UNC13A SLIT3	1.18e-05	175	36	4	a9f08e1e4c2997dcdd3e5d92daac480da19100b8
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FBN2 VWF CRIM1 TEK	1.21e-05	176	36	4	52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a
ToppCell	356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	FBN1 FCGBP MUC5AC AR	1.24e-05	177	36	4	709235694cc711b9b79690e23c94577b2ae06811
ToppCell	356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	FBN1 FCGBP MUC5AC AR	1.24e-05	177	36	4	7f9c2a45a994b32f15e5693f7cb873716a4eb568
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHC4 FBN1 AR SLIT3	1.26e-05	178	36	4	6d9ecfaeb50d562899380de379ebf7b99fd8adc9
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHC4 FBN1 AR SLIT3	1.26e-05	178	36	4	d3f518cd75b02e85d45cbb9b2eff30f0272512a8
ToppCell	15-Trachea-Epithelial-Goblet-like_secretory\|Trachea / Age, Tissue, Lineage and Cell class	SCNN1A GJB1 FCGBP MUC5AC	1.26e-05	178	36	4	f0557920b9b3e7c4f39938d1b524aa58711af4d2
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FBN2 VWF CRIM1 TEK	1.29e-05	179	36	4	8c9ed247e1c4d655b81ce2f24a9936a7cade718a
ToppCell	droplet-Limb_Muscle-Pre-Sort\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 GJB1 VWF CRIM1	1.32e-05	180	36	4	af2bafcd1b2082629de3ea336711add01565c4c4
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 GJB1 VWF CRIM1	1.32e-05	180	36	4	f29a995cf6e1a1836ed68b73258d9370bf3d4434
ToppCell	facs-Pancreas-Exocrine-24m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 GJB1 FCGBP OTOGL	1.32e-05	180	36	4	72310baeed848f2c483ae986cd73d2fb2cca7feb
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 STAB2 FBN2 OTOGL	1.44e-05	184	36	4	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 STAB2 FBN2 OTOGL	1.44e-05	184	36	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 STAB2 FBN2 OTOGL	1.44e-05	184	36	4	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 FBN1 FBN2 SLIT3	1.53e-05	187	36	4	4e553721fa5598cb211f44e3226280b7e6885484
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 FBN1 FBN2 SLIT3	1.53e-05	187	36	4	d36e7fc6125e7a4310499365022d38f34b757a73
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP2 FBN1 FBN2 SLIT3	1.53e-05	187	36	4	827eae63fabf6892a82ce7779b5f395958d3d628
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SCNN1A GJB1 FCGBP MUC5AC	1.57e-05	188	36	4	5901b276f2379abf486b8285957277e95f08464e
ToppCell	droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF CRIM1 TEK AR	1.63e-05	190	36	4	9d5242759546be0089981ef1877e4ed5f81face5
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWC2 FBN1 FBN2 SLIT3	1.63e-05	190	36	4	947807863a9b247c301c6cf63d6fd5a2c8018e66
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SAXO2 ZSWIM2 FCGBP MUC5AC	1.63e-05	190	36	4	2fdc024d3d673a0134b74b4c5a63afe924995730
ToppCell	PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SCNN1A DOCK3 LRP2 MUC5AC	1.67e-05	191	36	4	05731ece7867659c662f952812805f947032fe10
ToppCell	droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF CRIM1 TEK AR	1.70e-05	192	36	4	bcd8876235be503186f119653b39476488c0fa15
ToppCell	droplet-Pancreas-PANCREAS-30m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF CRIM1 TEK AR	1.70e-05	192	36	4	f4cd65e6c5b17bcabf45fe5b687246c72e7975f7
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SCNN1A DOCK3 LRP2 MUC5AC	1.70e-05	192	36	4	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SCNN1A GJB1 FCGBP MUC5AC	1.84e-05	196	36	4	c18874f37b90e6afacc562b2082b67ea8a7cb4a4
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SCNN1A GJB1 FCGBP MUC5AC	1.84e-05	196	36	4	91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SCNN1A GJB1 FCGBP MUC5AC	1.84e-05	196	36	4	e819088a74d29e958371aa851ac9c74ec55367b7
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	SCNN1A GJB1 FCGBP MUC5AC	1.84e-05	196	36	4	e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SCNN1A GJB1 FCGBP MUC5AC	1.84e-05	196	36	4	a4d05d85fbafa869df19bba3881020ea433d81fb
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-sinusoidal_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	STAB2 VWF CRIM1 TEK	1.88e-05	197	36	4	f1080d93acf1a4756d2f2c8cabd1fb50bc7bcd09
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FBN1 VWF GRM2 TEK	1.88e-05	197	36	4	ad4a3b5da2190be9495382a2952991e1de9f190d
ToppCell	Tracheal-10x5prime-Stromal-Peri/Epineurial_\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FBN1 FBN2 UNC13A SLIT3	1.88e-05	197	36	4	2cb1f557ce1400398975de94638126b4522567f3
ToppCell	Bronchial-10x5prime-Epithelial-Epi_submucosal-gland\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SCNN1A GJB1 FCGBP MUC5AC	1.88e-05	197	36	4	e2c820c4e4a6cd01ceb020473286e3f5d4e3718e
ToppCell	Mild_COVID-19-Epithelial-Basal/Club\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	SCNN1A GJB1 FCGBP MUC5AC	1.88e-05	197	36	4	4cc5b778e1e2c6c149160fa147c172977c0fa8eb
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ADH5 FBN1 ZYX SLIT3	1.92e-05	198	36	4	0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ADH5 FBN1 ZYX SLIT3	1.96e-05	199	36	4	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	ADH5 FBN1 ZYX SLIT3	1.96e-05	199	36	4	c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	ADH5 FBN1 ZYX SLIT3	2.00e-05	200	36	4	ab4fda0cc95cb8f80ea9f28745013f3248def820
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ADH5 FBN1 ZYX SLIT3	2.00e-05	200	36	4	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ADH5 FBN1 ZYX SLIT3	2.00e-05	200	36	4	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ADH5 FBN1 ZYX SLIT3	2.00e-05	200	36	4	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ADH5 FBN1 ZYX SLIT3	2.00e-05	200	36	4	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SCNN1A GJB1 FCGBP MUC5AC	2.00e-05	200	36	4	133853d0f55c63ebe94dd54151f9f1f90650a0d8
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SCNN1A GJB1 FCGBP MUC5AC	2.00e-05	200	36	4	8f811ddd84c037a250d124496b0fbb2e4717011c
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ADH5 FBN1 ZYX SLIT3	2.00e-05	200	36	4	3bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCell	Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)-\|Striatum / BrainAtlas - Mouse McCarroll V32	LRP2 ZSWIM2 MKRN2OS	1.15e-04	117	36	3	26dec09112532f351fb7a2202bae84c365707b40
ToppCell	Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)\|Striatum / BrainAtlas - Mouse McCarroll V32	LRP2 ZSWIM2 MKRN2OS	1.15e-04	117	36	3	db053c874e6739052dff1f91643e51b306236237
ToppCell	Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)--\|Striatum / BrainAtlas - Mouse McCarroll V32	LRP2 ZSWIM2 MKRN2OS	1.15e-04	117	36	3	80780223502d18f0d86a29ff3cb74aa8235103c7
ToppCell	Striatum-Macroglia-CSF_related-EPENDYMAL\|Striatum / BrainAtlas - Mouse McCarroll V32	LRP2 ZSWIM2 MKRN2OS	1.15e-04	117	36	3	40889f4a387846abbf54469cc4faf616bfe348d0
ToppCell	Striatum-Macroglia-CSF_related\|Striatum / BrainAtlas - Mouse McCarroll V32	LRP2 ZSWIM2 MKRN2OS	1.15e-04	117	36	3	e12e37e393257db85f7f5c13454095c44f59d374
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN2 VWF TEK	1.21e-04	119	36	3	c3f1223356e7f245a460ea5568a223e34e458dc1
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Intermediate\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	AR ZUP1 SLIT3	1.24e-04	120	36	3	eb5b88c47dd4a6f9b55ace24f19d4e81d4ed31e1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SHC4 FCGBP MKRN2OS	1.75e-04	135	36	3	c1752595de485075d71127411da33aaa191c426b
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCR2 STAB2 AR	1.99e-04	141	36	3	d3ce2218bfa9750795d920e1ef162ea44efb2e66
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCR2 STAB2 AR	2.12e-04	144	36	3	46177f0d6117e701bda86a99ac2a1b0e7ed66177
ToppCell	10x3'2.3-week_12-13-Myeloid_DC-DC-tDC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CCR2 SHC4 GRM3	2.17e-04	145	36	3	a6c291811bf62f1c13f1b4b396d75c2223cf1c7d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SHC4 FCGBP MKRN2OS	2.21e-04	146	36	3	d33bd571c2adf5f89e6f02e77d094c19edd4729c
ToppCell	10x5'-bone_marrow-Myeloid_Monocytic-Cycling_mono\|bone_marrow / Manually curated celltypes from each tissue	CCR2 ZSWIM2 FBN2	2.30e-04	148	36	3	de35eeefad0e27a0d127e2e4bedead2bddb75152
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	VWC2 FBN2 ASIC1	2.30e-04	148	36	3	9205b26e0d042b342cc643cda0f4f3f8bb392d00
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	STAB2 VWF TEK	2.39e-04	150	36	3	4f31867cb85253ff6d22f3b02ef972a42cb41123
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCNN1A LRP2 CCR2	2.54e-04	153	36	3	0ef7c45cdd854c79e527006034029767f8e108b2
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GJB1 FCGBP MUC5AC	2.63e-04	155	36	3	62b59cb32b12bd55b19e98786a866d788fc9e4bf
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 FBN2 TEK	2.63e-04	155	36	3	8fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell	PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	LRP2 ASIC1 AR	2.68e-04	156	36	3	605d95a900e1443d3f6aae163ef2e893d3293203
ToppCell	PND07-28-samps-Mesenchymal-Mesothelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	LRP2 ASIC1 AR	2.68e-04	156	36	3	574f761962a7dd3308bd41fc529dd3ea1b8625f8
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VWC2 FBN1 SLIT3	2.73e-04	157	36	3	f147e24f2ece82e1c54750868954d09b3c461804
ToppCell	facs-Spleen-nan-18m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCR2 SHC4 ZYX	2.73e-04	157	36	3	a84377028c661f8f3ecae0f6082abdd859faf0c8
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCR2 STAB2 AR	2.84e-04	159	36	3	5c7a099aa84ecc62bf9b5e1609e5b6b77889f175
ToppCell	facs-Heart-LA-24m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF ZYX SLIT3	2.94e-04	161	36	3	248487415a0601d57ef2a6692e22a61368d0b9c8
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOCK3 SHC4 SLIT3	2.94e-04	161	36	3	5fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCR2 STAB2 AR	3.05e-04	163	36	3	476e94e1d132eaaecb9e376bd32748a75ad22081
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VWC2 VWF TEK	3.11e-04	164	36	3	3cd80e6275f0f9b5667912139d15ebf5e6b17f2f
ToppCell	343B-Epithelial_cells-Epithelial-A_(AT2)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	SCNN1A LRP2 OTOGL	3.11e-04	164	36	3	beaa13a75c3bb72446c85084d75e9fe3f15fd3d4
ToppCell	343B-Epithelial_cells-Epithelial-A_(AT2)\|343B / Donor, Lineage, Cell class and subclass (all cells)	SCNN1A LRP2 OTOGL	3.11e-04	164	36	3	d005cfd821b87548b075120bffe65a0be9860463
ToppCell	PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCNN1A FCGBP MUC5AC	3.16e-04	165	36	3	baff639a7046fb5cacb70f341b6d24cef3519f8e
ToppCell	PND14-Epithelial-Epithelial_Airway-Neurosecretory\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCNN1A FCGBP MUC5AC	3.16e-04	165	36	3	6fdce8b23736409a23884ef3918638ffc067a86f
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 MUC5AC MKRN2OS	3.16e-04	165	36	3	f80665b75d43f1bf6919d59fc762e7e0bac653f2
ToppCell	PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCNN1A FCGBP MUC5AC	3.16e-04	165	36	3	dd4d36ff8efb89fee1fb4c48d1b8f46902119909
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF CRIM1 TEK	3.22e-04	166	36	3	7a45785a40b7425f97be67bab1c5ceb69b2bd85a
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	VWF CRIM1 TEK	3.22e-04	166	36	3	f7926ee266dcbf10df375cd921f1db5a2fa604f8
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF CRIM1 TEK	3.22e-04	166	36	3	bbd382812f8a84a5d99888de2d7cca3a8b5e4695
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SHC4 FBN2 ASIC1	3.28e-04	167	36	3	55c3c68af269fcf40f2b080ae4489523609ad388
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GJB1 FCGBP MUC5AC	3.28e-04	167	36	3	31633899aae852873a4887e72c621474b0a51a33
ToppCell	Adult-Epithelial-lung_goblet_cell-D122\|Adult / Lineage, Cell type, age group and donor	FCGBP MUC5AC AR	3.28e-04	167	36	3	6efbb2ef6adc8da5dd67210969f825f5cc8ed022
ToppCell	facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 VWF OTOGL	3.28e-04	167	36	3	a4a795751644b22af616335379e64ae95175180c
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN2 VWF TEK	3.28e-04	167	36	3	774f3264318b002d0df5d06d41d645366038d0bf
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VWF CRIM1 TEK	3.28e-04	167	36	3	d7fe24cdc4b55a9555ce9e20699f5036b88148e9
ToppCell	facs-GAT-Fat-18m-Epithelial\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GJB1 FCGBP MKRN2OS	3.34e-04	168	36	3	d6c8056b7d6b937bb91e6b33beeb1075dce1685c
ToppCell	facs-GAT-Fat-18m-Epithelial-epithelial_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GJB1 FCGBP MKRN2OS	3.34e-04	168	36	3	7102c52bf1b2ba67bb3700932181a2e0a6627711
ToppCell	facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF CRIM1 TEK	3.34e-04	168	36	3	06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCR2 STAB2 UNC13A	3.34e-04	168	36	3	a7eb28e15b591997f1aee09501cb20ae18beca08
ToppCell	facs-GAT-Fat-18m-Epithelial-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GJB1 FCGBP MKRN2OS	3.34e-04	168	36	3	68a2f9fd53b54023241acd1620cf24226f639c1b
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D122\|Adult / Lineage, Cell type, age group and donor	VWC2 VWF TEK	3.34e-04	168	36	3	8c3e1e45b422813bcdfa4273b1167db649a312f5
Computational	Porins / transporters.	SCNN1A LRP2 GJB1 TEK ASIC1 AR	4.07e-06	211	23	6	MODULE_63
Computational	Heart, liver, kidney and pancreas metabolic and xenobiotic response genes.	SCNN1A GJB1 FBN2 FCGBP VWF CRIM1 GRM2 ZYX AR	2.98e-05	835	23	9	MODULE_88
Computational	Genes in the cancer module 27.	LRP2 CCR2 GRM2 GRM3 TEK AR	7.80e-05	355	23	6	MODULE_27
Computational	Adhesion molecules.	FBN1 FBN2 VWF ZYX	2.07e-04	141	23	4	MODULE_122
Computational	Secreted signaling molecules.	GJB1 TEK ZYX AR	2.56e-04	149	23	4	MODULE_92
Computational	Placenta genes.	GJB1 FBN2 FCGBP VWF CRIM1 ZYX	3.34e-04	463	23	6	MODULE_38
Computational	Developmental processes.	GJB1 FBN1 TEK AR SLIT3	5.88e-04	333	23	5	MODULE_220
Computational	GPCR signaling pathways (immune and neuro).	CCR2 GRM2 GRM3	8.90e-04	90	23	3	MODULE_375
Computational	Ovary genes.	FBN1 VWF CRIM1 ZYX AR	9.25e-04	368	23	5	MODULE_1
Computational	Genes in the cancer module 128.	CCR2 GJB1 VWF	1.11e-03	97	23	3	MODULE_128
Computational	Genes in the cancer module 79.	CCR2 GJB1 VWF	1.17e-03	99	23	3	MODULE_79
Computational	Immune response.	CCR2 GJB1 VWF	1.21e-03	100	23	3	MODULE_170
Computational	Genes in the cancer module 55.	SCNN1A GJB1 FBN2 CRIM1 GRM2 ZYX AR	1.32e-03	832	23	7	MODULE_55
Computational	Trachea genes.	SCNN1A FCGBP VWF CRIM1 ZYX	1.58e-03	415	23	5	MODULE_6
Computational	Lung genes.	SCNN1A VWF CRIM1 TEK ZYX	1.93e-03	434	23	5	MODULE_5
Computational	Genes in the cancer module 289.	CCR2 GRM2 GRM3	2.24e-03	124	23	3	MODULE_289
Computational	Metal / Ca ion binding.	FBN1 FBN2 SLIT3	2.74e-03	133	23	3	MODULE_324
Computational	Neighborhood of TIMP2	FBN2 CRIM1	4.28e-03	46	23	2	GNF2_TIMP2
Computational	Neighborhood of KISS1	FBN2 CRIM1	4.85e-03	49	23	2	GNF2_KISS1
Computational	Genes upregulated in subsets of cells of a given type within various tumors	VWF TEK	5.04e-03	50	23	2	GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_2
Drug	AC1NSKBB	TAF1 GRM2 GRM3	1.03e-06	13	36	3	CID005311256
Drug	T2755	SCNN1A GRM2 GRM3 ASIC1	4.74e-06	71	36	4	CID000005514
Drug	2-amino-3-phosphonopropionic acid	ADH5 TAF1 GRM2 GRM3	6.23e-06	76	36	4	CID000003857
Drug	LY 379268	GRM2 GRM3	7.28e-06	3	36	2	ctd:C118218
Drug	isospaglumic acid	GRM2 GRM3	7.28e-06	3	36	2	ctd:C027172
Drug	AC1L1D63	TAF1 GRM2 GRM3	8.15e-06	25	36	3	CID000002209
Drug	PbTx-1	SCNN1A GJB1 ASIC1	1.03e-05	27	36	3	CID006437089
Drug	Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A	FBN1 STAB2 GRM3 ASIC1 MUC5AC	1.36e-05	196	36	5	2862_UP
Drug	LY 341495	GRM2 GRM3	1.46e-05	4	36	2	ctd:C114624
Drug	NPC 12626	GRM2 GRM3 AR	1.58e-05	31	36	3	CID000108099
Drug	rosavin	FBN1 FBN2 AR	1.74e-05	32	36	3	ctd:C529148
Drug	Acamprosate	GRM2 GRM3	2.42e-05	5	36	2	DB00659
Drug	4CPG	TAF1 GRM2 GRM3	2.95e-05	38	36	3	CID000005115
Drug	azetidine-2,4-dicarboxylic acid	GRM2 GRM3	5.08e-05	7	36	2	CID000005370
Drug	ketamine	SCNN1A VWF GRM2 GRM3 ASIC1	5.47e-05	262	36	5	CID000003821
Drug	funiferine N-oxide	FBN1 FBN2 AR	6.36e-05	49	36	3	CID000191631
Drug	methylenecyclopropylglycine	TAF1 GRM2 GRM3	6.36e-05	49	36	3	CID000441452
Drug	L-CCG-I	TAF1 GRM2 GRM3	6.76e-05	50	36	3	CID000001271
Drug	5-(4-((6-(allyloxy)-2,5,7,8-tetramethylchroman-2-yl)methoxy)-3-methoxybenzylidene)thiazolidine-2,4-dione	TAF1 AR	6.77e-05	8	36	2	ctd:C513003
Drug	cis-MCG-I	GRM2 GRM3	6.77e-05	8	36	2	CID003035584
Drug	LY354740	TAF1 GRM2 GRM3	7.18e-05	51	36	3	CID000114827
Drug	Amiloride	SCNN1A ASIC1	8.69e-05	9	36	2	DB00594
Drug	nitazoxanide	AR SLIT3	8.69e-05	9	36	2	ctd:C041747
Drug	AC1N21PP	GRM2 GRM3	8.69e-05	9	36	2	CID004014619
Drug	1,3-cyclopentanedicarboxylic acid	GRM2 GRM3	8.69e-05	9	36	2	CID000107216
Drug	mM PEP	GRM2 GRM3	8.69e-05	9	36	2	CID005311462
Drug	2-phenylglycine	TAF1 GRM2 GRM3	9.00e-05	55	36	3	CID000003866
Drug	Anidulafungin	GJB1 GRM2 GRM3 AR	1.08e-04	157	36	4	CID000166548
Drug	NS-105	GRM2 GRM3	1.09e-04	10	36	2	CID000198695
Drug	AC-474	DOCK3 VWF AR	1.11e-04	59	36	3	CID000002999
Drug	Propolis	FBN1 FBN2 AR	1.17e-04	60	36	3	ctd:D011429
Drug	3,5-dihydroxyphenylglycine	TAF1 GRM2 GRM3	1.17e-04	60	36	3	CID000108001
Drug	cyclobutylene AP5	GRM2 GRM3	1.32e-04	11	36	2	CID000126582
Drug	3-chlorophenol	CCR2 AR	1.32e-04	11	36	2	ctd:C030682
Drug	gabapentin	SCNN1A GRM2 GRM3 ASIC1	1.43e-04	169	36	4	CID000003446
Drug	mexiletine	SCNN1A ZSWIM2 ASIC1	1.55e-04	66	36	3	CID000004178
Drug	Atpa	GRM2 GRM3	1.59e-04	12	36	2	CID000002252
Drug	Piperidines	CCR2 GRM2	1.59e-04	12	36	2	ctd:D010880
Drug	riluzole	SCNN1A GRM2 GRM3 ASIC1	1.60e-04	174	36	4	CID000005070
Drug	DCG-IV	TAF1 GRM2 GRM3	1.70e-04	68	36	3	CID000115114
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A	ASIC1 MUC5AC ZYX AR	1.79e-04	179	36	4	1640_UP
Drug	strychnine HCl	SCNN1A GRM2 GRM3 ASIC1	1.87e-04	181	36	4	CID000005304
Drug	bicyclo[3.1.0]hexane	GRM2 GRM3	1.88e-04	13	36	2	CID000067510
Drug	Mspg	GRM2 GRM3	1.88e-04	13	36	2	CID003964410
Drug	MSOPPE	GRM2 GRM3	1.88e-04	13	36	2	CID005311463
Drug	AC1L1E5T	FBN2 GRM2 GRM3	2.18e-04	74	36	3	CID000002653
Drug	2-methyl-6-styrylpyridine	GRM2 GRM3	2.19e-04	14	36	2	CID000235382
Drug	MTPG	GRM2 GRM3	2.19e-04	14	36	2	CID005311456
Drug	PF-00875133-00 [351322-64-0]; Up 200; 10uM; MCF7; HT_HG-U133A	DOCK3 ASIC1 MUC5AC ZYX	2.43e-04	194	36	4	5923_UP
Drug	3,2'-dimethyl-4-aminobiphenyl	GJB1 AR	2.52e-04	15	36	2	CID000025948
Drug	Pargyline hydrochloride [306-07-0]; Up 200; 20.4uM; HL60; HG-U133A	ZNF142 STAB2 FBN2 SLIT3	2.53e-04	196	36	4	1418_UP
Drug	3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A	FBN1 GRM2 ASIC1 MUC5AC	2.53e-04	196	36	4	6402_DN
Drug	Epicatechin-(-) [154-23-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A	DOCK3 STAB2 ASIC1 MUC5AC	2.53e-04	196	36	4	4419_UP
Drug	Vitamin K2 [11032-49-8]; Up 200; 9uM; PC3; HT_HG-U133A	LRP2 GRM2 MUC5AC UNC13A	2.58e-04	197	36	4	3798_UP
Drug	Hemicholinium bromide [312-45-8]; Down 200; 7uM; MCF7; HT_HG-U133A	LRP2 STAB2 GTDC1 ASIC1	2.58e-04	197	36	4	3216_DN
Drug	Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A	NCBP1 GRM3 TEK ASIC1	2.63e-04	198	36	4	2234_UP
Drug	Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; PC3; HT_HG-U133A	LRP2 FBN1 STAB2 ASIC1	2.63e-04	198	36	4	6354_UP
Drug	Azacyclonol [115-46-8]; Up 200; 15uM; HL60; HG-U133A	SCNN1A GJB1 STAB2 SLIT3	2.63e-04	198	36	4	2020_UP
Drug	Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A	LRP2 GRM2 GRM3 SLIT3	2.63e-04	198	36	4	3748_UP
Drug	Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A	SCNN1A LRP2 ASIC1 MUC5AC	2.68e-04	199	36	4	5079_UP
Drug	Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; HL60; HG-U133A	SCNN1A GJB1 STAB2 SLIT3	2.68e-04	199	36	4	1373_UP
Drug	(S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A	SCNN1A LRP2 TAF1 STAB2	2.68e-04	199	36	4	6444_UP
Drug	valdecoxib; Down 200; 10uM; MCF7; HT_HG-U133A	FBN1 GRM2 ASIC1 MUC5AC	2.68e-04	199	36	4	6403_DN
Drug	Paroxetine maleate [64006-44-6]; Down 200; 1uM; MCF7; HT_HG-U133A	NCBP1 STAB2 CRIM1 GTDC1	2.73e-04	200	36	4	3904_DN
Drug	N-phenylanthranilic acid; Down 200; 10uM; MCF7; HG-U133A	FBN2 CRIM1 GRM2 TEK	2.73e-04	200	36	4	317_DN
Drug	GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A	LRP2 NCBP1 STAB2 CRIM1	2.73e-04	200	36	4	3240_DN
Drug	ethylglutamate	GRM2 GRM3	2.88e-04	16	36	2	CID000014241
Drug	2-PMPA	GRM2 GRM3	2.88e-04	16	36	2	CID010130754
Drug	ethanol	ADH5 SCNN1A ZNF142 VWF GRM3 ASIC1 MUC5AC	2.91e-04	837	36	7	CID000000702
Drug	Ovalbumin	LRP2 FBN1 MUC5AC	2.95e-04	82	36	3	ctd:D010047
Drug	3HPG	GRM2 GRM3	3.26e-04	17	36	2	CID000001217
Drug	O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate	CRIM1 GRM2 UNC13A SLIT3	3.35e-04	211	36	4	ctd:C009618
Drug	AC1NB8R3	TAF1 GRM2 GRM3 ZYX	3.47e-04	213	36	4	CID004489307
Drug	xenon	VWF GRM3 AR	3.63e-04	88	36	3	CID000023991
Drug	S-acetyl	GRM2 GRM3	3.66e-04	18	36	2	CID000137849
Drug	moricizine	SCNN1A ZSWIM2	3.66e-04	18	36	2	CID000034632
Drug	acromelic acid A	GRM2 GRM3	3.66e-04	18	36	2	CID000108086
Drug	aurintricarboxylic acid	VWF GRM2 GRM3	4.01e-04	91	36	3	CID000002259
Drug	2-amino-4-phosphonobutyric acid	TAF1 GRM2 GRM3	4.01e-04	91	36	3	CID000002207
Drug	aminocyclopentane	GRM2 GRM3	4.09e-04	19	36	2	CID000002906
Drug	LY382884	GRM2 GRM3	4.09e-04	19	36	2	CID000656723
Drug	diprafenone	SCNN1A ASIC1	4.09e-04	19	36	2	CID000071249
Drug	4-carboxy-3-hydroxyphenylglycine	GRM2 GRM3	4.54e-04	20	36	2	CID000001297
Drug	P-31	TAF1 VWF	4.54e-04	20	36	2	CID000017959
Drug	AC1L1GHE	TAF1 FBN2 AR	4.69e-04	96	36	3	CID000003684
Drug	puerarin	FBN1 FBN2 AR	4.98e-04	98	36	3	ctd:C033607
Drug	AC1NBUB1	GRM2 GRM3	5.01e-04	21	36	2	CID004473866
Drug	CX546	GRM2 GRM3	5.01e-04	21	36	2	CID000002890
Drug	icilin	GRM2 ASIC1	5.01e-04	21	36	2	CID000161930
Drug	3,4-dihydroxyphenylglycine	GRM2 GRM3	5.01e-04	21	36	2	CID000027915
Drug	TAAD	FBN1 FBN2	5.01e-04	21	36	2	CID000133445
Drug	nitrofen	SCNN1A FBN1 AR SLIT3	5.19e-04	237	36	4	ctd:C007350
Drug	Tritolyl Phosphates	GJB1 AR	5.50e-04	22	36	2	ctd:D014317
Drug	N-palmitoyl-l-methionine	GRM2 GRM3	5.50e-04	22	36	2	CID000486207
Drug	Chlorogenic Acid	FBN1 FBN2 AR	5.76e-04	103	36	3	ctd:D002726
Drug	MSOP	GRM2 GRM3	6.02e-04	23	36	2	CID003964633
Drug	YM90K	GRM2 GRM3	6.02e-04	23	36	2	CID005486547
Drug	racemethorphan	SCNN1A GRM2 GRM3	6.44e-04	107	36	3	CID000003008
Drug	2-chloro-N6-cyclopentyladenosine	GRM2 GRM3	6.56e-04	24	36	2	CID000001547
Drug	CGP 39653	GRM2 GRM3	6.56e-04	24	36	2	CID006437837
Disease	Epilepsy, Benign Psychomotor, Childhood	GRM2 GRM3 TEK	2.66e-06	23	35	3	C0393672
Disease	Epilepsy, Lateral Temporal	GRM2 GRM3 TEK	2.66e-06	23	35	3	C0393682
Disease	Uncinate Epilepsy	GRM2 GRM3 TEK	2.66e-06	23	35	3	C0014558
Disease	Epilepsy, Temporal Lobe	GRM2 GRM3 TEK	2.66e-06	23	35	3	C0014556
Disease	Addicted to cocaine	GRM2 GRM3	4.10e-06	3	35	2	C0858355
Disease	connective tissue disease (implicated_via_orthology)	FBN1 FBN2	4.10e-06	3	35	2	DOID:65 (implicated_via_orthology)
Disease	scoliosis (is_implicated_in)	FBN1 FBN2	8.19e-06	4	35	2	DOID:0060249 (is_implicated_in)
Disease	Alcoholic Intoxication, Chronic	ADH5 VWF GRM2 GRM3 AR	1.55e-05	268	35	5	C0001973
Disease	mesangial proliferative glomerulonephritis (biomarker_via_orthology)	FBN1 VWF	3.81e-05	8	35	2	DOID:4783 (biomarker_via_orthology)
Disease	Metabolic Bone Disorder	ANKRD11 LRP2	1.23e-04	14	35	2	C0005944
Disease	respiratory quotient	VWC2 UNC13A	1.23e-04	14	35	2	EFO_0005189
Disease	Proteinuria	LRP2 VWF	1.42e-04	15	35	2	HP_0000093
Disease	Osteopenia	ANKRD11 LRP2	1.42e-04	15	35	2	C0029453
Disease	factor VIII measurement, Ischemic stroke	STAB2 VWF	2.31e-04	19	35	2	EFO_0004630, HP_0002140
Disease	attention deficit hyperactivity disorder (is_implicated_in)	DOCK3 AR	2.56e-04	20	35	2	DOID:1094 (is_implicated_in)
Disease	sexual dimorphism measurement	ANKRD11 DOCK3 ZNF142 FBN1 CRIM1 ASIC1 SLIT3	2.73e-04	1106	35	7	EFO_0021796
Disease	gastric ulcer (biomarker_via_orthology)	TEK MUC5AC	2.83e-04	21	35	2	DOID:10808 (biomarker_via_orthology)
Disease	factor VIII measurement, von Willebrand factor measurement	STAB2 VWF	4.71e-04	27	35	2	EFO_0004629, EFO_0004630
Disease	macrophage inflammatory protein 1b measurement	DOCK3 CCR2 GRM2	5.63e-04	136	35	3	EFO_0008219
Disease	Ischemic stroke, von Willebrand factor measurement	STAB2 VWF	5.82e-04	30	35	2	EFO_0004629, HP_0002140
Disease	factor VIII measurement, venous thromboembolism	STAB2 VWF	7.49e-04	34	35	2	EFO_0004286, EFO_0004630
Disease	COVID-19 symptoms measurement	CCR2 MUC5AC	7.94e-04	35	35	2	EFO_0600019
Disease	body surface area	ANKRD11 FBN1 FBN2 CRIM1 SLIT3	9.14e-04	643	35	5	EFO_0022196
Disease	venous thromboembolism, factor VII measurement	ADH5 VWF	9.35e-04	38	35	2	EFO_0004286, EFO_0004619
Disease	thioredoxin domain-containing protein 12 measurement	DOCK3 GRM2	9.85e-04	39	35	2	EFO_0008298
Disease	factor VIII measurement	STAB2 VWF	1.04e-03	40	35	2	EFO_0004630
Disease	Diaphragmatic Hernia	LRP2 SLIT3	1.09e-03	41	35	2	C0019284
Disease	venous thromboembolism, von Willebrand factor measurement	STAB2 VWF	1.14e-03	42	35	2	EFO_0004286, EFO_0004629
Disease	amino acid measurement	LRP2 VWC2 VWF GTDC1 SLIT3	1.16e-03	678	35	5	EFO_0005134

Protein segments in the cluster

Peptide	Gene	Start	Entry
GPECYELQVCVKDYC	UNC13A	1611	Q9UPW8
CCITPQAPQCYAEYV	ANKRD11	2456	Q6UB99
PLYIPQCGECKFCLN	ADH5	91	P11766
EVCCWLCIPCQPYEY	GRM2	516	Q14416
VCCWICIPCEPYEYL	GRM3	526	Q14832
LCPANPTCIYKYGDE	NCBP1	476	Q09161
FPCKNGRCVPNYYLC	LRP2	1031	P98164
PPICYNYEIRIQCCE	MUC5AC	2031	P98088
DYYFPPQKTCLICGD	AR	551	P10275
LYLGLPCCKEDYNGC	DOCK3	561	Q8IZD9
AYCPAYVVKSVPGCE	FCGBP	341	Q9Y6R7
SPEACYECKINGYPK	FBN1	2711	P35555
CERYYVPEGECCPVC	CRIM1	376	Q9NZV1
CQKEDSVYVCGPYFP	CCR2	181	P41597
VKCDVYPCPNTVDCF	GJB1	166	P08034
CICPPGYEVKSENCI	FBN2	2041	P35556
AMLEAVYCGCYPLCP	GTDC1	376	Q4AE62
VYCGCYPLCPKDLVY	GTDC1	381	Q4AE62
IKECGCAYIFYPRPQ	SCNN1A	426	P37088
YCSLSCPEGKEYQPC	OTOGL	1801	Q3ZCN5
LKCQCPNLYYGELCE	MUC17	4156	Q685J3
DPGAPDCKYGETVYC	TAF1	711	P21675
YCTPEQYKECADPAL	ASIC1	336	P78348
MAYCPIQCEKLCYLP	SHC4	401	Q6S5L8
CTQDPVELYRCACPY	SLIT3	931	O75094
YKCPLCPYACGNLAN	ZNF513	416	Q8N8E2
DPVYEPDQCCPICKN	VWC2	261	Q2TAL6
CVPKAQCPCYYDGEI	VWF	701	P04275
CEKYIYSFSVPQCCP	MKRN2OS	16	H3BPM6
CECYSAYTGPKCDKP	STAB2	181	Q8WWQ8
QEGCKSYVFCLPDPY	TEK	271	Q02763
SCGSDYCPYEIVKQP	SAXO2	16	Q658L1
PIEGKCYKCTECIEY	ZSWIM2	241	Q8NEG5
PLYDCPMCGLICTNY	ZUP1	191	Q96AP4
PYCEGCYTDTLEKCN	ZYX	431	Q15942
NPYLCTECGKGYTCL	ZNF883	11	P0CG24
TGLKPYQCPECEYCT	ZNF142	1531	P52746